Product NDC: | 45802-966 |
Proprietary Name: | Erythromycin |
Non Proprietary Name: | Erythromycin |
Active Ingredient(s): | 20 mg/g & nbsp; Erythromycin |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-966 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063211 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080612 |
Package NDC: | 45802-966-94 |
Package Description: | 1 TUBE in 1 CARTON (45802-966-94) > 30 g in 1 TUBE |
NDC Code | 45802-966-94 |
Proprietary Name | Erythromycin |
Package Description | 1 TUBE in 1 CARTON (45802-966-94) > 30 g in 1 TUBE |
Product NDC | 45802-966 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Erythromycin |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20080612 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | ERYTHROMYCIN |
Strength Number | 20 |
Strength Unit | mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |